Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lupus Nephritis × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Stomatitis 1 Neoplasms 1 Neoplasm Metastasis 1 Lupus Nephritis 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia 1 Inflammation 1 Fatigue Syndrome, Chronic 1 Bone Neoplasms 1 Bites and Stings 1 Arthritis, Rheumatoid 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00447265 2013-02-12

Etanercept for the Treatment of Lupus Nephritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Terminated

1 enrolled 15 charts

Lupus Nephritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡